Posted on Leave a comment

Therma Bright’s Investment Case Just Got Stronger As Approval On Permanent Insurance Codes Gets Closer

Therma Bright (TSXV:THRM) (OTCQB:TBRIF), a developer of a wide range of leading edge, proprietary diagnostic and medical device technologies that address some of today’s most important medical and healthcare challenges, appears to be positioned for major growth based on one important upcoming catalyst. For some background, Therma Bright (TSXV:THRM) (OTCQB:TBRIF) sells Venowave, a compact, battery-operated […]

Posted on Leave a comment

Revolutionizing Trucking: How Portal Transport Solutions is Paving the Way with Its Fleet Builder Program and Driver Staffing Services

In an industry as dynamic and essential as trucking, efficiency, and reliability are the cornerstones of success. Portal Transport Solutions (PTS) stands out as a beacon of innovation, providing comprehensive solutions through its Fleet Builder Program and expert driver staffing services. With glowing reviews from satisfied clients, PTS is setting new standards in the trucking […]

Posted on Leave a comment

PGIM and SIPioneer Announce Strategic Collaboration to Develop Super AIPGIM Quantitative Trading System

PGIM, a global leader in investment management, is proud to announce a strategic partnership with Smart Investment Pioneer (SIPioneer), a trailblazer in the financial services industry. Together, they are embarking on a groundbreaking project to develop the advanced Super AIPGIM quantitative trading system. This collaboration aims to revolutionize investment advisory services by combining the strengths […]

Posted on Leave a comment

Achondroplasia Market and Epidemiology 2032: Treatment Market, Therapies, Companies, FDA Approvals, Epidemiology and Forecast by DelveInsight | Ribomic Inc, Sanofi, Changchun GeneScience Pharma, QED

The Achondroplasia Market Market Forecast report offers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia market trends in the 7MM. DelveInsight’s “Achondroplasia Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Achondroplasia, historical and forecasted epidemiology as well as the Achondroplasia market trends in […]

Posted on Leave a comment

Morningstar PR & Associates, AI-Powered PR Firm, Announces Strategic Partnership with Blip Billboards to Empower Nonprofits and Small Businesses

CHICAGO, IL – June 06, 2024 – Morningstar PR & Associates, a leading public relations firm harnessing the power of Artificial Intelligence for data-driven strategies, today announced a groundbreaking partnership with Blip Billboards, a prominent digital billboard company. This innovative collaboration aims to democratize access to high-impact advertising for non-profit organizations and small businesses.  Through […]

Posted on Leave a comment

Farrah O. Appointed Chief Marketing Officer for Kher Beauty Lab’s Miami Division

Kher Beauty Lab welcomes new marketing leadership to strengthen its natural and sustainable beauty commitment. Kher Beauty Lab is pleased to announce the appointment of Farrah O. as the new Chief Marketing Officer for its Florida Miami Division. With a strong background in business development and management and a passion for natural beauty, Farrah brings […]

Posted on Leave a comment

ABSSSI Market Forecast 2034: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight | Kimyrsa, Sivextro, Nuzyra, Baxdela, Dalbavancin, Orbactiv, Levonadifloxacin/Linezolid,etc

ABSSSI Market ABSSSI companies are Merck, Pfizer, Paratek Pharmaceutical, Melinta Therapeutics, Allergan, Novexel, Teva Pharma, Wockhardt, Durata Therapeutics, Cubist Pharmaceutical, Sonescence, Forest Laboratories, The Medicine Company and more. (Albany, USA) DelveInsight’s “ABSSSI Market Insights, Epidemiology, and Market Forecast-2034” report delivers an in-depth understanding of ABSSSI, historical and forecasted epidemiology as well as the ABSSSI market […]

Posted on Leave a comment

Bone Metastasis Market Forecast 2032: FDA, EMA and PDMA Approvals, Epidemiology, Therapies, Companies by DelveInsight | XGEVA (denosumab), XOFIGO (radium-223 dichloride), Cabozantinib, 9-ING-41, more

Bone Metastasis Market Bone Metastasis companies are Amgen, Actuate Therapeutics, Exelixi, Daiichi Sankyo Inc, Pfizer, Eli Lilly and Company, Novartis, Bayer, and Many Others. (Albany, USA) DelveInsight’s “Bone Metastasis Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Bone Metastasis, historical and forecasted epidemiology as well as the Bone Metastasis market trends […]

Posted on Leave a comment

Non-Small Cell Lung Cancer Market to Register Incremental Growth During the Forecast Period (2023-2032), Asserts DelveInsight | AbbVie, Xcovery, Sanofi, NeoImmune Tech, Merck KGaA and Pfizer, Mirati

Non-Small Cell Lung Cancer Market Forecast report offers an in-depth understanding of the Non-Small Cell Lung Cancer, historical and forecasted epidemiology as well as the Non-Small Cell Lung Cancer market trends in the 7MM. DelveInsight’s “Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Non-Small Cell Lung […]